Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis - Nature Medicine
- ️Jenq, Robert R.
- ️Mon Nov 12 2018
Data availability
Patient-related data not included in the paper were generated as part of clinical trials and may be subject to patient confidentiality. Any data and materials that can be shared will be released via a Material Transfer Agreement. Sequence data has been deposited at the European Genome-phenome Archive (EGA), which is hosted by the EBI and the CRG, under accession number EGAS00001003217.
Change history
27 November 2018
In the version of this article originally published, an author was missing from the author list. Alexander J. Lazar should have been included between Jorge M. Blando and James P. Allison. The author has been added to the list, and the author contributions section has been updated to include Alexander J. Lazar’s contribution to the study. The error has been corrected in the print, PDF and HTML versions of the manuscript.
References
Michot, J. M. et al. Eur. J. Cancer 54, 139–148 (2016).
Cramer, P. & Bresalier, R. S. Curr. Gastroenterol. Rep. 19, 3 (2017).
Chen, J. H., Pezhouh, M. K., Lauwers, G. Y. & Masia, R. Am. J. Surg. Pathol. 41, 643–654 (2017).
Dadu, R., Zobniw, C. & Diab, A. Cancer J. 22, 121–129 (2016).
Bertrand, A., Kostine, M., Barnetche, T., Truchetet, M. E. & Schaeverbeke, T. BMC Med. 13, 211 (2015).
Horvat, T. Z. et al. J. Clin. Oncol. 33, 3193–3198 (2015).
Beck, K. E. et al. J. Clin. Oncol. 24, 2283–2289 (2006).
Johnston, R. L., Lutzky, J., Chodhry, A. & Barkin, J. S. Dig. Dis. Sci. 54, 2538–2540 (2009).
Minor, D. R., Chin, K. & Kashani-Sabet, M. Cancer Biother. Radiopharm. 24, 321–325 (2009).
Borody, T. J. & Khoruts, A. Nat. Rev. Gastroenterol. Hepatol. 9, 88–96 (2011).
Gopalakrishnan, V. et al. Science 359, 97–103 (2018).
Matson, V. et al. Science 359, 104–108 (2018).
Routy, B. et al. Science 359, 91–97 (2018).
Dubin, K. et al. Nat. Commun. 7, 10391 (2016).
Vetizou, M. et al. Science 350, 1079–1084 (2015).
Chaput, N. et al. Ann. Oncol. 28, 1368–1379 (2017).
Wang, F., Yin, Q., Chen, L. & Davis, M. M. Proc. Natl Acad. Sci. USA 115, 157–161 (2018).
Kappeler, A. & Mueller, C. Histol. Histopathol. 15, 167–172 (2000).
Nancey, S. et al. Gastroenterology 131, 485–496 (2006).
Png, C. W. et al. Am. J. Gastroenterol. 105, 2420–2428 (2010).
Litvak, Y., Byndloss, M. X., Tsolis, R. M. & Baumler, A. J. Curr. Opin. Microbiol. 39, 1–6 (2017).
Jenq, R. R. et al. Biol. Blood Marrow Transplant. 21, 1373–1383 (2015).
van Nood, E. et al. N. Engl. J. Med. 368, 407–415 (2013).
Caporaso, J. G. et al. ISME J. 6, 1621–1624 (2012).
Rognes, T., Flouri, T., Nichols, B., Quince, C. & Mahe, F. PeerJ 4, e2584 (2016).
Caporaso, J. G. et al. Nat. Methods 7, 335–336 (2010).
Schloss, P. D. et al. Appl. Environ. Microbiol. 75, 7537–7541 (2009).
Lozupone, C., Lladser, M. E., Knights, D., Stombaugh, J. & Knight, R. ISME J. 5, 169–172 (2011).
Stack, E. C., Wang, C., Roman, K. A. & Hoyt, C. C. Methods 70, 46–58 (2014).
Abu-Sbeih, H. et al. J. Immunother. Cancer 6, 1–11 (2018).
Acknowledgments
We are grateful for the following funding support: Andrew Sabin Family Fellows Program (private donation to J.A.W); MD Anderson Cancer Center’s Melanoma Moon Shot Program (grant no. 710499-80-111538-19, to J.A.W.); American Association for Cancer Research Stand Up to Cancer (grant no. SU2C-AACR-IRG-19-17, to J.A.W.); National Institutes of Health (grant no. R01 CA219896-01A1, to J.A.W.); National Institutes of Health (grant no. R01 HL124112, to R.R.J.); Cancer Prevention and Research Institute of Texas (grant no. RR160089, to R.R.J.).
Author information
Author notes
These authors contributed equally: Yinghong Wang, Diana H. Wiesnoski, Beth A. Helmink.
These authors jointly supervised this work: Jennifer A. Wargo, Robert R. Jenq.
Authors and Affiliations
Department of Gastroenterology, Hepatology & Nutrition, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Yinghong Wang, Hamzah Abu-Sbeih, Gottumukkala S. Raju & John R. Stroehlein
Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Diana H. Wiesnoski, Christopher A. Sanchez, Chia-Chi Chang, Alexander J. Lazar, Jennifer A. Wargo & Robert R. Jenq
Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Beth A. Helmink, Vancheswaran Gopalakrishnan & Jennifer A. Wargo
Department of Internal Medicine, Baylor College of Medicine, Houston, TX, USA
Kati Choi
Center for Infectious Diseases, School of Public Health, The University of Texas, Houston, TX, USA
Hebert L. DuPont & Zhi-Dong Jiang
Kelsey Research Foundation, Houston, TX, USA
Hebert L. DuPont
Department of Translational Molecular Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Edwin R. Parra, Alejandro Francisco-Cruz & Michael T. Tetzlaff
Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Matthew T. Campbell, Jianjun Gao, Sumit K. Subudhi & Padmanee Sharma
Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Dipen M. Maru, Alexander J. Lazar & Michael T. Tetzlaff
Department of Immunology, Division of Basic Science Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Jorge M. Blando, James P. Allison & Padmanee Sharma
Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Robert R. Jenq
Authors
- Yinghong Wang
You can also search for this author inPubMed Google Scholar
- Diana H. Wiesnoski
You can also search for this author inPubMed Google Scholar
- Beth A. Helmink
You can also search for this author inPubMed Google Scholar
- Vancheswaran Gopalakrishnan
You can also search for this author inPubMed Google Scholar
- Kati Choi
You can also search for this author inPubMed Google Scholar
- Hebert L. DuPont
You can also search for this author inPubMed Google Scholar
- Zhi-Dong Jiang
You can also search for this author inPubMed Google Scholar
- Hamzah Abu-Sbeih
You can also search for this author inPubMed Google Scholar
- Christopher A. Sanchez
You can also search for this author inPubMed Google Scholar
- Chia-Chi Chang
You can also search for this author inPubMed Google Scholar
- Edwin R. Parra
You can also search for this author inPubMed Google Scholar
- Alejandro Francisco-Cruz
You can also search for this author inPubMed Google Scholar
- Gottumukkala S. Raju
You can also search for this author inPubMed Google Scholar
- John R. Stroehlein
You can also search for this author inPubMed Google Scholar
- Matthew T. Campbell
You can also search for this author inPubMed Google Scholar
- Jianjun Gao
You can also search for this author inPubMed Google Scholar
- Sumit K. Subudhi
You can also search for this author inPubMed Google Scholar
- Dipen M. Maru
You can also search for this author inPubMed Google Scholar
- Jorge M. Blando
You can also search for this author inPubMed Google Scholar
- Alexander J. Lazar
You can also search for this author inPubMed Google Scholar
- James P. Allison
You can also search for this author inPubMed Google Scholar
- Padmanee Sharma
You can also search for this author inPubMed Google Scholar
- Michael T. Tetzlaff
You can also search for this author inPubMed Google Scholar
- Jennifer A. Wargo
You can also search for this author inPubMed Google Scholar
- Robert R. Jenq
You can also search for this author inPubMed Google Scholar
Contributions
Y.W. recruited and treated patients. Y.W., D.H.W., B.A.H., V.G., K.C., H.L.D., Z.-D.J., H.A.-S. C.A.S., C.-C.C., E.R.P., A.F.-C., G.S.R., J.R.S, M.T.C., J.G., S.K.S., D.M.M., J.M.B., A.J.L., J.P.A., P.S., M.T.T., J.A.W., and R.R.J. completed stool and tissue immunohistochemistry studies and analyzed/interpreted data. Y.W., B.A.H., V.G., M.T.T., J.A.W., and R.R.J. prepared the manuscript. All authors approved the manuscript.
Corresponding author
Correspondence to Yinghong Wang.
Ethics declarations
Competing interests
J.A.W. and V.G. are inventors on a US patent application (PCT/US17/53,717) submitted by The University of Texas MD Anderson Cancer Center that covers methods to enhance checkpoint blockade therapy by the microbiome., J.A.W. is a paid speaker for Imedex, Dava Oncology, Omniprex, Illumina, Gilead, MedImmune and Bristol Meyers Squibb. J.A.W. is a consultant / advisory board member for Roche-Genentech, Novartis, Astra-Zeneca, Glaxo Smith Klein, Bristol Meyers Squibb, Merck, and Microbiome DX. J.A.W. also receives clinical trial support from Glaxo Smith Klein, Roche-Genentech, Bristol Meyers Squibb, and Novartis. V.G. is a consultant at Microbiome DX, and ExpertConnect. R.R.J. is on the scientific advisory board for Seres Therapeutics, Inc., has consulted for Ziopharm Oncology and Microbiome Dx, and holds patents licensed to Seres Therapeutics, Inc. M.T.T. serves on the advisory board for Novartis, Seattle Genetics, and Myriad Genetics. J.A.W., P.S., and J.P.A. are members of the Parker Institute for Cancer Immunotherapy at MD Anderson Cancer Center. P.S. is a consultant for Constellation, Kite Pharma, Neon, BioAtla, Pieris Pharmaceuticals, Oncolytics Biotech, Merck, BioMx, Forty-Seven, Polaris, Apricity, Marker Therapeutics, Codiak, Jounce Therapeutics, and is also a stockholder from Jounce Therapeutics, Neon, BioAtla, Forty-Seven, Apricity, Polaris, Marker Therapeutics, Codiak, and Kite Pharma. J.P.A. is a stockholder for Jounce Therapeutics, Neon, BioAtla, Forty-Seven, Apricity, Polaris, Marker Therapeutics, Codiak, and Kite Pharma. J.P.A. is also a consultant for Jounce Therapeutics, Neon, Amgen, Forty-Seven, Apricity, Polaris, Marker Therapeutics, Codiak, BioAlta LLC, and Tvardi Therapeutics. The other authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Wang, Y., Wiesnoski, D.H., Helmink, B.A. et al. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. Nat Med 24, 1804–1808 (2018). https://doi.org/10.1038/s41591-018-0238-9
Received: 27 February 2018
Accepted: 27 September 2018
Published: 12 November 2018
Issue Date: December 2018
DOI: https://doi.org/10.1038/s41591-018-0238-9